NEW YORK — There are racial and gender disparities in the enrollment of participants in clinical trials for diabetic macular edema, according to a poster presented at the American Society of Retina Specialists annual meeting.
In a retrospective cohort study, Theodore S. Bowe, MD, and colleagues analyzed the data of Diabetic Retinopathy Clinical Research Network clinical trials and industry-sponsored phase 3 trials on DME conducted in the U.S. between 2000 and 2020.
They found that white and male participants were relatively overrepresented in all trials. Overall, white participants made